Harmful hydrogen peroxide cellular levels are minimized by the enzyme glutathione peroxidase (GP) using GSH as a reductant
In clinical trials such as SURPASS and SURPASS-2, tirzepatide demonstrated comparable or superior efficacy to semaglutide in improving HbA1c and reducing BMI, with weight reductions of 5.4 to 10.5 kg and up to 2.34% HbA1c reduction at 40 weeks.16,17 Tirzepatide is administered as a weekly injection beginning at 2.5 mg weekly and increasing to 5 mg after four weeks
Beretta G, Artali R, Regazzoni L, et al
This process is achieved through its mechanism of action, which involves triggering the secretion of GH from the pituitary gland [5]
Treatments, which are usually successful, include surgery, hormone therapy, radioactive iodine, radiation, and in some cases chemotherapy